Data base for:

  • Conferences
  • Research funding opportunities
  • Competitions / Awards

Register for free and add any data by yourself!

Filter conferences

 
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
 
      
      
 
      
 
      
      
      
      
      
      
      
      
      
      
4th Microbiome Movement - Drug Development Summit Europe 2020 - London, UK

4th Microbiome Movement - Drug Development Summit Europe 2020 - London, UK

Categories

Date of beginning

Tuesday, 04 February 2020

Duration

3 days

City

London

Country

United Kingdom

Contact

Customer Services

E-Mail

This email address is being protected from spambots. You need JavaScript enabled to view it.

Memo

Part of the foremost conference series for microbiome researchers in industry, the 4th Microbiome Movement ā€“ Drug Development Europe 2020 returns to unite leading scientists from the biopharmaceutical and academic community to pursue the causal role of the microbiome in disease, and help create a new generation of microbiome-targeted therapeutics with predictable modes of action and consistent clinical outcomes. Across three days of case-studies, discussion and debates, learn how industry and academic leaders are understanding microbiome functionality across key therapeutic modalities, leveraging big data platforms to deduce causality, and overcoming regulatory, clinical and manufacturing hurdles to further accelerate their pipeline across new disease targets. At this critical time, and as the microbiome community waits for the first clinical breakthrough, join your peers and unlock the potential of the human microbiome to create the next generation of microbiome-based therapeutics and diagnostic candidates of the future. Early booking and group discounts apply, start-up and academic rates are available - see the website for details. Prices: Drug Developers: Pharma and Biotech- Standard Pricing- Conference + 2 Workshops: GBP 2397.00,Drug Developers: Pharma and Biotech- Standard Pricing- Conference + 1 Workshop: GBP 2098.00,Drug Developers: Pharma and Biotech- Standard Pricing- Conference Only: GBP 1799.00,Drug Developers: Pharma and Biotech- Standard Pricing- Conference + 3 Workshops: GBP 2696.00,Start-Up, Academic and Not For Profit - Standard Pricing- Conference + 3 Workshops: GBP 2296.00,Start-Up, Academic and Not For Profit - Standard Pricing- Conference + 2 Workshops: GBP 1997.00,Start-Up, Academic and Not For Profit - Standard Pricing- Conference + 1 Workshop: GBP 1698.00,Start-Up, Academic and Not For Profit - Standard Pricing- Conference Only: GBP 1399.00Workshop Only: GBP 399.00 On Tuesday February 04, 2020 at 8:30 am (ends Thursday February 06, 2020 at 5:50 pm) URLs: Tickets: https://go.evvnt.com/534064-2?pid=5569 Brochure: https://go.evvnt.com/534064-3?pid=5569 Speakers: Lothar Steidler, Chief Technology Officer, ActoBio Therapeutics, Andrea Doolan, CEO, Atlantia Food Clinical Trials, Rikke Nielsen, CEO and Founder, Beo Therapeutics, Adrien Nivoliez, CEO, biose industrie, Elran Haber, CEO, Biomica Ltd., Assaf Oron, Chief Business Officer, BiomX, Dora Nagy-Szakal, CMO, Biotia, Inc., Jeffrey Heiser, Director Microbiology, Boston Analytical, Luc Sterkman, CEO, Caelus Health, Arne Materna, Vice President Product, CosmosID, Jean de Gunzburg, CSO, DaVolterra, Sebastien Guery, Human Microbiome Venture Leader, Dupont Microbiome Venture, Igor Stzepourginski, Head of Preclinical Operations, Eligo Biosciences, Romain Dā€™Ailiere, Head of Preclinical Research and Co-Founder, EverImmune, Rafael Suarez, Senior Director Emerging Brands, Global Marketing, Gastroenterology and Mirobiome, Ferring Pharmaceuticals, Kristin Wannerberger, Director R&D Alliance Management, Ferring Pharmaceuticals, Anna Williamson, Senior Director Oncology Business and Head of UK Business Development, Genentech, Suhyun Kim, Postdoctoral fellow, Harvard University, Shahram Lavasani, CEO and Founder, Immune Biotech, Georges Rawadi, CEO, LNC Therapeutics, Jason Ryan, Upstream Manager, Luina Bio, Sophie Durand, Co-Founder, Microbiome Foundation, Mike Romanos, CEO, Microbiotica, Trevor Lawley, CSO, Microbiotica, Herwig Bachmann, Expertise Group Leader, Fermentation NIZO, Maria Akerman, Director Process R&D, Oxthera, Tomas de Wouters, CEO and Co-Founder, PharmaBIome, Aurelien Baudot, International Business Developer, ProDigest, Ryan Wilson, Head of Live-Bio Programmes, Quay Pharma, Ken Blount, CSO, Rebiotix, Alain Roulet, Laboratory Director, Vaiomer, Kareem Barghout, Co-Founder, VastBiome, Bruce Roberts, CSO, Vedanta Biosciences, Imke Mulder, Director of Research, 4D Pharma, Damien Keogh, CEO, Maiden Therapeutics, Christophe Lacroix, Professor, Food Biotechnology, ETH Zuric Venue details: The Tower Hotel, St Katharine's Way, London, England, E1W 1LD, United Kingdom